Katharine Knobil
Overview
Katharine Knobil received an average of $2M in total compensation, including $313K in salary, at Kaleido Biosciences from 2018 to 2020.
Source: SEC filings on May 5, 2021 and May 8, 2020.
Related executives
We found five more executives who work or worked at Kaleido Biosciences.